These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 19010230

  • 21. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
    Kaiser GM, Frühauf NR, Lang H, Sauerwein W, Sotiropoulos GC, Zöpf T, Grabellus F, Wittig A, Oldhafer KJ, Malagó M, Broelsch CE.
    Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
    [Abstract] [Full Text] [Related]

  • 22. Survival and an overview of decision-making in patients with cholangiocarcinoma.
    Forsmo HM, Horn A, Viste A, Hoem D, Ovrebo K.
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):412-7. PubMed ID: 18693178
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Palliative surgical bypass versus percutaneous transhepatic biliary drainage on unresectable hilar cholangiocarcinoma.
    Wongkonkitsin N, Phugkhem A, Jenwitheesuk K, Saeseow OT, Bhudhisawasdi V.
    J Med Assoc Thai; 2006 Nov; 89(11):1890-5. PubMed ID: 17205870
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Transplantation for cholangiocarcinoma: when and for whom?
    Rea DJ, Rosen CB, Nagorney DM, Heimbach JK, Gores GJ.
    Surg Oncol Clin N Am; 2009 Apr; 18(2):325-37, ix. PubMed ID: 19306815
    [Abstract] [Full Text] [Related]

  • 29. Intrahepatic cholangiocarcinoma: indication for transplantation.
    Pascher A, Jonas S, Neuhaus P.
    J Hepatobiliary Pancreat Surg; 2003 Apr; 10(4):282-7. PubMed ID: 14598146
    [Abstract] [Full Text] [Related]

  • 30. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period.
    Becker NS, Rodriguez JA, Barshes NR, O'Mahony CA, Goss JA, Aloia TA.
    J Gastrointest Surg; 2008 Jan; 12(1):117-22. PubMed ID: 17963015
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [An analysis on prognostic factors of hilar cholangiocarcinoma].
    Zhou LX, Zhang ZW, Xu ZY.
    Zhonghua Yi Xue Za Zhi; 2009 May 12; 89(18):1275-7. PubMed ID: 19595185
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical analysis of curative resection with hemihepatectomy for advanced hilar cholangiocarcinoma].
    Sun Y, Wu ZY, Hao CY, Huang XF, Wang K, Bao Q, Qian HG, Xing BC.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 26; 88(8):527-30. PubMed ID: 18649767
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Extent of liver resection for hilar cholangiocarcinoma.
    Chen XP, Lau WY, Huang ZY, Zhang ZW, Chen YF, Zhang WG, Qiu FZ.
    Br J Surg; 2009 Oct 26; 96(10):1167-75. PubMed ID: 19705374
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.